Tactorum

Tactorum is revolutionizing pain research from the ground up. We're a biotechnology company tackling one of preclinical research's biggest challenges: measuring pain accurately and consistently. Our flagship ARM (Automated Reproducible Mechano-stimulator) technology bridges a critical gap that's held back both scientific progress and patient care for too long. The research impact: ARM replaces subjective pain assessment with standardized, objective quantification. For scientists, this means cleaner data, bulletproof reproducibility, and experiments that actually scale. By eliminating human bias and boosting throughput, researchers can map pain mechanisms with unprecedented precision—cutting years off the path from lab bench to clinical trial. The patient promise: Better preclinical data means better drugs reach patients faster. ARM's high-fidelity measurements dramatically improve the odds that therapies—especially non-opioid alternatives—will actually work in humans. This isn't just about speed; it's about getting the right treatments to the right patients, with diagnostics and interventions tailored to individual pain profiles. The result? A future where pain relief is faster, safer, and far more effective.